董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Susan A. Willetts | -- | Director | -- | 2.41万美元 | 未持股 | 2015-03-05 |
| Robert J. Palay | 男 | Founder, Chief Executive Officer and Chairman of the Board. | 58 | 159.05万美元 | 未持股 | 2015-03-05 |
| Thomas M. Palay | 男 | Founder, President, Vice Chairman of the Board and Director | 61 | 159.05万美元 | 未持股 | 2015-03-05 |
| Kenneth C. Hunt | 男 | Director | 75 | 12.93万美元 | 未持股 | 2015-03-05 |
| Craig T. January | 男 | Director | 77 | 16.30万美元 | 未持股 | 2015-03-05 |
| Stanley D. Rose | 男 | Director | 69 | 10.84万美元 | 未持股 | 2015-03-05 |
| Sheli Z. Rosenberg | 女 | Director | 83 | 13.11万美元 | 未持股 | 2015-03-05 |
| James A. Thomson | 男 | Director | 66 | 96.47万美元 | 未持股 | 2015-03-05 |
| Michael J. Van Handel | -- | Director | 65 | 12.80万美元 | 未持股 | 2015-03-05 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Timothy D. Daley | 男 | Vice President, Chief Financial Officer and Treasurer | 46 | 未披露 | 未持股 | 2015-03-05 |
| Robert J. Palay | 男 | Founder, Chief Executive Officer and Chairman of the Board. | 58 | 159.05万美元 | 未持股 | 2015-03-05 |
| Thomas M. Palay | 男 | Founder, President, Vice Chairman of the Board and Director | 61 | 159.05万美元 | 未持股 | 2015-03-05 |
| Emile F. Nuwaysir | 男 | Vice President and Chief Operating Officer | 46 | 90.35万美元 | 未持股 | 2015-03-05 |
| Christopher Parker | 男 | Vice President and Chief Commercial Officer | 50 | 89.85万美元 | 未持股 | 2015-03-05 |
| Nicholas J. Seay | 男 | Vice President and Chief Technology Officer | 64 | 未披露 | 未持股 | 2015-03-05 |
| Anna M. Geyso | 女 | Senior Vice President, General Counsel and Secretary | 51 | 未披露 | 未持股 | 2015-03-05 |
董事简历
中英对照 | 中文 | 英文- Susan A. Willetts
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Robert J. Palay
-
Robert J. Palay，是我们Cellular Dynamics International, Inc.公司的创立者并自2007年担任董事会主席和CEO。他之前在我们公司的前任公司成立时起直至2008年，担任董事会主席和CEO。他还联合创立了分子生物学工具公司NimbleGen Systems, Inc.，并于1999年至2007年担任董事会主席，于1999年至2000年担任该公司CEO。在这些公司成立时起，他担任一般合伙人的管理者或多个Tactics II机构的管理者，这些机构是私人投资工具，这些机构并在2014年1月之前是我们公司的部分主要股东。他在哈佛学院（Harvard College）以优异成绩获得学士学位，在凯洛格管理研究生院（the J.L. Kellogg Graduate School of Management）获得硕士学位，在西北大学法学院（Northwestern University School of Law）获得法学博士学位。
Robert J. Palay is one of our founders and has served as Chairman of the Board and as Chief Executive Officer since 2007. Mr. Palay previously served as chairman of the board and chief executive officer of each of our predecessors from their founding until 2008. He also co-founded NimbleGen Systems, Inc., a molecular biology tools company, and served as its chairman of the board from 1999 to 2007 and as its chief executive officer from 1999 to 2000. Since their inception, Mr. Palay has served as a manager of the general partner or manager of each of the various Tactics II entities, which are private investment vehicles and were among our principal shareholders prior to distributions made in 2014. He received a A.B., magna cum laude, from Harvard College, an M.M. from the J.L. Kellogg Graduate School of Management and a J.D. from the Northwestern University School of Law. - Robert J. Palay，是我们Cellular Dynamics International, Inc.公司的创立者并自2007年担任董事会主席和CEO。他之前在我们公司的前任公司成立时起直至2008年，担任董事会主席和CEO。他还联合创立了分子生物学工具公司NimbleGen Systems, Inc.，并于1999年至2007年担任董事会主席，于1999年至2000年担任该公司CEO。在这些公司成立时起，他担任一般合伙人的管理者或多个Tactics II机构的管理者，这些机构是私人投资工具，这些机构并在2014年1月之前是我们公司的部分主要股东。他在哈佛学院（Harvard College）以优异成绩获得学士学位，在凯洛格管理研究生院（the J.L. Kellogg Graduate School of Management）获得硕士学位，在西北大学法学院（Northwestern University School of Law）获得法学博士学位。
- Robert J. Palay is one of our founders and has served as Chairman of the Board and as Chief Executive Officer since 2007. Mr. Palay previously served as chairman of the board and chief executive officer of each of our predecessors from their founding until 2008. He also co-founded NimbleGen Systems, Inc., a molecular biology tools company, and served as its chairman of the board from 1999 to 2007 and as its chief executive officer from 1999 to 2000. Since their inception, Mr. Palay has served as a manager of the general partner or manager of each of the various Tactics II entities, which are private investment vehicles and were among our principal shareholders prior to distributions made in 2014. He received a A.B., magna cum laude, from Harvard College, an M.M. from the J.L. Kellogg Graduate School of Management and a J.D. from the Northwestern University School of Law.
- Thomas M. Palay
-
Thomas M. Palay，博士，是我们Cellular Dynamics International, Inc.公司的创建者之一，自2007年担任我们Cellular Dynamics International, Inc.公司的董事会副主席和总裁。他之前在我们Cellular Dynamics International, Inc.公司的各个前身公司成立时，担任其董事会副主席和总裁。他还联合创立了NimbleGen Systems, Inc.公司，于1999年至2007年担任该公司董事会副主席、副总裁和首席运营官。自公司的成立起，他担任一般合伙人经理或Tactics II实体的经理。他于1980年代成为威斯康星大学法学院（the University of Wisconsin Law School）教学人员。他于2010年在Foley & Lardner-Bascom法学教授职位上退休。他以优异成绩获得塔夫斯大学（Tufts University）学士学位，在宾夕法尼亚大学（the University of Pennsylvania）获得法学博士学位和博士学位。
Thomas M. Palay is one of our founders and has served as Vice Chairman of the Board and as President since 2007. Dr. Palay previously served as vice chairman of the board and president of each of our predecessors from their founding until 2008. He also co-founded NimbleGen Systems, Inc. and served as its vice chairman of the board, vice president and chief operating officer from 1999 to 2007. Since their inception, Dr. Palay has served as a manager of the general partner or manager of each of the Tactics II entities. Dr. Palay joined the faculty of the University of Wisconsin Law School in 1980. He retired as the Foley & Lardner-Bascom Professor of Law in 2010. Dr. Palay received a B.A., summa cum laude, from Tufts University, a J.D. from the University of Pennsylvania and a Ph.D. from the University of Pennsylvania. - Thomas M. Palay，博士，是我们Cellular Dynamics International, Inc.公司的创建者之一，自2007年担任我们Cellular Dynamics International, Inc.公司的董事会副主席和总裁。他之前在我们Cellular Dynamics International, Inc.公司的各个前身公司成立时，担任其董事会副主席和总裁。他还联合创立了NimbleGen Systems, Inc.公司，于1999年至2007年担任该公司董事会副主席、副总裁和首席运营官。自公司的成立起，他担任一般合伙人经理或Tactics II实体的经理。他于1980年代成为威斯康星大学法学院（the University of Wisconsin Law School）教学人员。他于2010年在Foley & Lardner-Bascom法学教授职位上退休。他以优异成绩获得塔夫斯大学（Tufts University）学士学位，在宾夕法尼亚大学（the University of Pennsylvania）获得法学博士学位和博士学位。
- Thomas M. Palay is one of our founders and has served as Vice Chairman of the Board and as President since 2007. Dr. Palay previously served as vice chairman of the board and president of each of our predecessors from their founding until 2008. He also co-founded NimbleGen Systems, Inc. and served as its vice chairman of the board, vice president and chief operating officer from 1999 to 2007. Since their inception, Dr. Palay has served as a manager of the general partner or manager of each of the Tactics II entities. Dr. Palay joined the faculty of the University of Wisconsin Law School in 1980. He retired as the Foley & Lardner-Bascom Professor of Law in 2010. Dr. Palay received a B.A., summa cum laude, from Tufts University, a J.D. from the University of Pennsylvania and a Ph.D. from the University of Pennsylvania.
- Kenneth C. Hunt
-
Kenneth C. Hunt，自2009年担任我公司董事会成员。他于2008年至2013年1月担任ManpowerGroup Inc.公司高级副总裁、法律总顾问和秘书。在加入ManpowerGroup Inc.公司之前，他于1981年至2007年是Godfrey & Kahn, S.C。公司股东。他在密歇根大学（University of Michigan）获得航空航天工程学位，并在杜克大学法学院（Duke University Law School）获得荣誉法学博士学位。是依照我们第15条修正和重申的股东协议，他被我们公司大多数A级优先股已发行股票的持有人选举为我们公司董事会成员。
Kenneth C. Hunt,Mr. Hunt has served on our board of directors since 2009. He served as senior vice president, general counsel and secretary of ManpowerGroup Inc., from 2008 until January 2013. Prior to joining ManpowerGroup, Mr. Hunt was a shareholder at Godfrey & Kahn, S.C. from 1981 to 2007. He received a degree in Aerospace Engineering from the University of Michigan and a J.D., with distinction, from Duke University Law School. Mr. Hunt was selected to serve on our board of directors by the holders of a majority of our outstanding shares of Series A Preferred Stock, pursuant to our Fifth Amended and Restated Shareholder Agreement. - Kenneth C. Hunt，自2009年担任我公司董事会成员。他于2008年至2013年1月担任ManpowerGroup Inc.公司高级副总裁、法律总顾问和秘书。在加入ManpowerGroup Inc.公司之前，他于1981年至2007年是Godfrey & Kahn, S.C。公司股东。他在密歇根大学（University of Michigan）获得航空航天工程学位，并在杜克大学法学院（Duke University Law School）获得荣誉法学博士学位。是依照我们第15条修正和重申的股东协议，他被我们公司大多数A级优先股已发行股票的持有人选举为我们公司董事会成员。
- Kenneth C. Hunt,Mr. Hunt has served on our board of directors since 2009. He served as senior vice president, general counsel and secretary of ManpowerGroup Inc., from 2008 until January 2013. Prior to joining ManpowerGroup, Mr. Hunt was a shareholder at Godfrey & Kahn, S.C. from 1981 to 2007. He received a degree in Aerospace Engineering from the University of Michigan and a J.D., with distinction, from Duke University Law School. Mr. Hunt was selected to serve on our board of directors by the holders of a majority of our outstanding shares of Series A Preferred Stock, pursuant to our Fifth Amended and Restated Shareholder Agreement.
- Craig T. January
-
Craig T. January，医学博士。
Craig T. January, MD, Ph.D.,Craig T. January, MD, Ph.D. - Craig T. January，医学博士。
- Craig T. January, MD, Ph.D.,Craig T. January, MD, Ph.D.
- Stanley D. Rose
-
Stanley D. Rose，博士，自2009年担任我们Cellular Dynamics International, Inc.公司的董事会成员。他于2008年Rose Ventures, Inc.公司成立起担任总裁，该公司是一家威斯康星州为生命科技公司提供顾问服务和投资的公司。他自2013年5月担任Transplant Genomics Inc.公总裁和CEO，于2012年担任Invenra公司董事，于2009年担任Point Judith Capital公司的投资组合公司Nabsys的董事。他还与2003年至2007年担任NimbleGen Systems, Inc.总裁、CEO和董事会成员，Roche Holdings, Inc.公司于2007年被NimbleGen Systems, Inc.收购之后，直到2008年他担任Roche NimbleGen公司的CEO。加入NimbleGen Systems, Inc.之前，他于1997年共同创立了一家基因芯片仪器公司Genetic MicroSystems。他在康奈尔大学（Cornell University）获得学士学位，在麻省理工学院（Massachusetts Institute of Technology）获得生物学博士学位。
Stanley D. Rose, Ph.D.,Dr. Rose has served on our board of directors since 2009. Dr. Rose has served as president of Rose Ventures, Inc., a Wisconsin-based firm that provides consulting services and makes investments in life science tool companies, since its founding in 2008. Dr. Rose has served as president and chief executive officer of Transplant Genomics Inc. since March 2013 as a director of Invenra since 2012 and as a director since 2009 of Nabsys, a portfolio company of Point Judith Capital. He also served as president, chief executive officer and a member of the board of directors of NimbleGen Systems, Inc. from 2003 to 2007 continuing on until 2008 as chief executive officer of Roche NimbleGen following Roche Holdings, Inc.’s acquisition of NimbleGen Systems, Inc. in 2007. Prior to NimbleGen Systems, Inc., Dr. Rose co-founded Genetic MicroSystems, a microarray instruments company, in 1997. Dr. Rose received a B.A. from Cornell University and a Ph.D. in Biology from the Massachusetts Institute of Technology. - Stanley D. Rose，博士，自2009年担任我们Cellular Dynamics International, Inc.公司的董事会成员。他于2008年Rose Ventures, Inc.公司成立起担任总裁，该公司是一家威斯康星州为生命科技公司提供顾问服务和投资的公司。他自2013年5月担任Transplant Genomics Inc.公总裁和CEO，于2012年担任Invenra公司董事，于2009年担任Point Judith Capital公司的投资组合公司Nabsys的董事。他还与2003年至2007年担任NimbleGen Systems, Inc.总裁、CEO和董事会成员，Roche Holdings, Inc.公司于2007年被NimbleGen Systems, Inc.收购之后，直到2008年他担任Roche NimbleGen公司的CEO。加入NimbleGen Systems, Inc.之前，他于1997年共同创立了一家基因芯片仪器公司Genetic MicroSystems。他在康奈尔大学（Cornell University）获得学士学位，在麻省理工学院（Massachusetts Institute of Technology）获得生物学博士学位。
- Stanley D. Rose, Ph.D.,Dr. Rose has served on our board of directors since 2009. Dr. Rose has served as president of Rose Ventures, Inc., a Wisconsin-based firm that provides consulting services and makes investments in life science tool companies, since its founding in 2008. Dr. Rose has served as president and chief executive officer of Transplant Genomics Inc. since March 2013 as a director of Invenra since 2012 and as a director since 2009 of Nabsys, a portfolio company of Point Judith Capital. He also served as president, chief executive officer and a member of the board of directors of NimbleGen Systems, Inc. from 2003 to 2007 continuing on until 2008 as chief executive officer of Roche NimbleGen following Roche Holdings, Inc.’s acquisition of NimbleGen Systems, Inc. in 2007. Prior to NimbleGen Systems, Inc., Dr. Rose co-founded Genetic MicroSystems, a microarray instruments company, in 1997. Dr. Rose received a B.A. from Cornell University and a Ph.D. in Biology from the Massachusetts Institute of Technology.
- Sheli Z. Rosenberg
-
Sheli Z. Rosenberg，她自2013年3月担任我们Cellular Dynamics International, Inc.公司董事。她于2011年至2014年在Skadden, Arps, Slate, Meagher & Flom LLP公司担任法律顾问。2014年她成为公司的顾问。她之前于2008年至2010年担任Equity Residential公司董事，于2008年至2010年担任VS Caremark Corporation公司董事，于2008年至2009年担任Avis Budget Group, Inc.公司董事。她于2000年至2003年担任投资公司Equity Group Investments, LLC的副主席，于1999年至2000年担任该公司总裁和CEO。1994年至1999年期间，她担任对房地产和企业进行占有、管理和投资公司Equity Group Investments, Inc.公司的总裁、CEO和董事。她还于1980年至1997年担任律师事务所Rosenberg & Liebentritt, P.C。的负责人。她目前是Equity Life Style Properties公司、Nanosphere, Inc.公司、Spirit Realty Capital公司、Strategic Hotels & Resorts, Inc.公司和Ventas, Inc.公司的董事，她于2014年5月在Ventas, Inc.公司公司退休。她是凯洛格管理学院女性执行官中心（the Center for Executive Women at the Kellogg School of Management）的联合创立者和原总裁，并且于2003年至2007年担任西北大学凯洛格管理研究生院（Northwestern University's J.L. Kellogg Graduate School of Business）兼职教授。
Sheli Z. Rosenberg,Ms. Rosenberg has served on our board of directors since March 2013. Ms. Rosenberg was at Skadden, Arps, Slate, Meagher & Flom LLP as Of Counsel from 2011 to 2014. In 2014 she became a consultant to the firm. She previously served as a director of Equity Residential from prior to 2008 to 2010 of CVS Caremark Corporation from prior to 2008 to 2010 and of Avis Budget Group, Inc. from prior to 2008 to 2009. She was the Vice Chairman of Equity Group Investments, LLC,an investment company, from 2000 to 2003 and its President and Chief Executive Officer from 1999 to 2000. From 1994 to 1999 Ms. Rosenberg served as President, Chief Executive Officer and a director of Equity Group Investments, Inc., an owner, manager and financier of real estate and corporations. She was also a principal in the law firm of Rosenberg & Liebentritt, P.C. from 1980 to 1997. Ms. Rosenberg is currently a director of Equity Life Style Properties, Nanosphere, Inc., Spirit Realty Capital, Strategic Hotels & Resorts, Inc., and Ventas, Inc. from which she is retiring in May 2014. Ms. Rosenberg is the co-founder and former President of the Center for Executive Women at the Kellogg School of Management, and she was an Adjunct Professor at Northwestern University’s J.L. Kellogg Graduate School of Business from 2003 to 2007. - Sheli Z. Rosenberg，她自2013年3月担任我们Cellular Dynamics International, Inc.公司董事。她于2011年至2014年在Skadden, Arps, Slate, Meagher & Flom LLP公司担任法律顾问。2014年她成为公司的顾问。她之前于2008年至2010年担任Equity Residential公司董事，于2008年至2010年担任VS Caremark Corporation公司董事，于2008年至2009年担任Avis Budget Group, Inc.公司董事。她于2000年至2003年担任投资公司Equity Group Investments, LLC的副主席，于1999年至2000年担任该公司总裁和CEO。1994年至1999年期间，她担任对房地产和企业进行占有、管理和投资公司Equity Group Investments, Inc.公司的总裁、CEO和董事。她还于1980年至1997年担任律师事务所Rosenberg & Liebentritt, P.C。的负责人。她目前是Equity Life Style Properties公司、Nanosphere, Inc.公司、Spirit Realty Capital公司、Strategic Hotels & Resorts, Inc.公司和Ventas, Inc.公司的董事，她于2014年5月在Ventas, Inc.公司公司退休。她是凯洛格管理学院女性执行官中心（the Center for Executive Women at the Kellogg School of Management）的联合创立者和原总裁，并且于2003年至2007年担任西北大学凯洛格管理研究生院（Northwestern University's J.L. Kellogg Graduate School of Business）兼职教授。
- Sheli Z. Rosenberg,Ms. Rosenberg has served on our board of directors since March 2013. Ms. Rosenberg was at Skadden, Arps, Slate, Meagher & Flom LLP as Of Counsel from 2011 to 2014. In 2014 she became a consultant to the firm. She previously served as a director of Equity Residential from prior to 2008 to 2010 of CVS Caremark Corporation from prior to 2008 to 2010 and of Avis Budget Group, Inc. from prior to 2008 to 2009. She was the Vice Chairman of Equity Group Investments, LLC,an investment company, from 2000 to 2003 and its President and Chief Executive Officer from 1999 to 2000. From 1994 to 1999 Ms. Rosenberg served as President, Chief Executive Officer and a director of Equity Group Investments, Inc., an owner, manager and financier of real estate and corporations. She was also a principal in the law firm of Rosenberg & Liebentritt, P.C. from 1980 to 1997. Ms. Rosenberg is currently a director of Equity Life Style Properties, Nanosphere, Inc., Spirit Realty Capital, Strategic Hotels & Resorts, Inc., and Ventas, Inc. from which she is retiring in May 2014. Ms. Rosenberg is the co-founder and former President of the Center for Executive Women at the Kellogg School of Management, and she was an Adjunct Professor at Northwestern University’s J.L. Kellogg Graduate School of Business from 2003 to 2007.
- James A. Thomson
-
James A. Thomson，兽医学博士，是我们公司的创立者之一，自2007年担任首席科学家和董事会成员。他在宾夕法尼亚大学（the University of Pennsylvania）获得兽医学博士学位。他是National Academy of Sciences会员，并自2008年在Morgridge Institute for Research担任再生生物部门主管，并自2003年担任威斯康星麦迪逊大学（the University of Wisconsin-Madison）John D. MacArthur解剖学教授。他在人类胚胎干细胞方面的工作被精选为《科学》杂志（Science Magazine）1999年年度科学突破性进展，且他的实验室所做的工作被《时代》杂志（TIME Magazine）引用为三个不同年份的年度十大发现之一，包括人类胚胎干细胞分离（1998年）、人类诱导多能干细胞分离（2007年）、人类基因组图谱的合作绘制（2009年）。他在2001年和2007年登上《时代》杂志（TIME Magazine）封面“美国最好的科学和医学”，成为《时代》杂志（TIME Magazine）“世界最有影响力人物”。他发表过150多篇学术文献、综述，并有超过30多项专利。
James A. Thomson, VMD, Ph.D.,Dr. Thomson is one of our founders and has served as our Chief Scientific Officer and as a member of our board of directors since 2007. He received a VMD and a Ph.D. from the University of Pennsylvania. He is a member of the National Academy of Sciences, and has served as the Director of Regenerative Biology at the Morgridge Institute for Research since 2008 and as the John D. MacArthur Professor of Anatomy at the University of Wisconsin-Madison since 2003. Dr. Thomson’s derivation of human ES cells was featured as Science Magazine’s “Scientific Breakthrough of the Year” in 1999 and work from Dr. Thomson’s laboratory has been cited in TIME Magazine’s “Top 10 Discoveries of the Year” on three separate occasions, including the isolation of human ES cells 1998 #1 the isolation of human iPS cells (2007 #1) and the collaborative mapping of the human epigenome (2009 #2). He was featured on the cover of TIME Magazine’s “America’s Best in Science and Medicine” in 2001 and in 2007 was named one of TIME Magazine’s “100 Most Influential People in the World.” Dr. Thomson has published over 150 scientific, peer-reviewed papers and has been an inventor on over 30 issued patents. - James A. Thomson，兽医学博士，是我们公司的创立者之一，自2007年担任首席科学家和董事会成员。他在宾夕法尼亚大学（the University of Pennsylvania）获得兽医学博士学位。他是National Academy of Sciences会员，并自2008年在Morgridge Institute for Research担任再生生物部门主管，并自2003年担任威斯康星麦迪逊大学（the University of Wisconsin-Madison）John D. MacArthur解剖学教授。他在人类胚胎干细胞方面的工作被精选为《科学》杂志（Science Magazine）1999年年度科学突破性进展，且他的实验室所做的工作被《时代》杂志（TIME Magazine）引用为三个不同年份的年度十大发现之一，包括人类胚胎干细胞分离（1998年）、人类诱导多能干细胞分离（2007年）、人类基因组图谱的合作绘制（2009年）。他在2001年和2007年登上《时代》杂志（TIME Magazine）封面“美国最好的科学和医学”，成为《时代》杂志（TIME Magazine）“世界最有影响力人物”。他发表过150多篇学术文献、综述，并有超过30多项专利。
- James A. Thomson, VMD, Ph.D.,Dr. Thomson is one of our founders and has served as our Chief Scientific Officer and as a member of our board of directors since 2007. He received a VMD and a Ph.D. from the University of Pennsylvania. He is a member of the National Academy of Sciences, and has served as the Director of Regenerative Biology at the Morgridge Institute for Research since 2008 and as the John D. MacArthur Professor of Anatomy at the University of Wisconsin-Madison since 2003. Dr. Thomson’s derivation of human ES cells was featured as Science Magazine’s “Scientific Breakthrough of the Year” in 1999 and work from Dr. Thomson’s laboratory has been cited in TIME Magazine’s “Top 10 Discoveries of the Year” on three separate occasions, including the isolation of human ES cells 1998 #1 the isolation of human iPS cells (2007 #1) and the collaborative mapping of the human epigenome (2009 #2). He was featured on the cover of TIME Magazine’s “America’s Best in Science and Medicine” in 2001 and in 2007 was named one of TIME Magazine’s “100 Most Influential People in the World.” Dr. Thomson has published over 150 scientific, peer-reviewed papers and has been an inventor on over 30 issued patents.
- Michael J. Van Handel
-
Michael J. Van Handel,ManpowerGroup Inc.（全球领先的劳动力解决方案公司）（纽约证券交易所代码：MAN）：高级执行副总裁（2016年至2017年），首席财务官（1998年至2016年），其他几个高级财务和会计职位（1989年至1998年）；ManpowerGroup Inc.：董事（2017年至今），治理和可持续发展委员会成员（2022年至今），主席（2024年至今）Marquette大学会计学学士，工商管理硕士Wisconsin大学麦迪逊分校银行与金融专业。
Michael J. Van Handel,ManpowerGroup Inc., a leading global workforce solutions company (NYSE: MAN):Senior Executive Vice President (2016 to 2017),Chief Financial Officer (1998 to 2016),Several other senior finance and accounting positions (1989 to 1998);ManpowerGroup Inc.:Director (2017 to present),Governance and Sustainability Committee member (2022 to present), Chair (2024 to present);Education:B.S. in Accounting, Marquette University,M.B.A. in Banking and Finance, University of Wisconsin - Madison. - Michael J. Van Handel,ManpowerGroup Inc.（全球领先的劳动力解决方案公司）（纽约证券交易所代码：MAN）：高级执行副总裁（2016年至2017年），首席财务官（1998年至2016年），其他几个高级财务和会计职位（1989年至1998年）；ManpowerGroup Inc.：董事（2017年至今），治理和可持续发展委员会成员（2022年至今），主席（2024年至今）Marquette大学会计学学士，工商管理硕士Wisconsin大学麦迪逊分校银行与金融专业。
- Michael J. Van Handel,ManpowerGroup Inc., a leading global workforce solutions company (NYSE: MAN):Senior Executive Vice President (2016 to 2017),Chief Financial Officer (1998 to 2016),Several other senior finance and accounting positions (1989 to 1998);ManpowerGroup Inc.:Director (2017 to present),Governance and Sustainability Committee member (2022 to present), Chair (2024 to present);Education:B.S. in Accounting, Marquette University,M.B.A. in Banking and Finance, University of Wisconsin - Madison.
高管简历
中英对照 | 中文 | 英文- Timothy D. Daley
Timothy D. Daley从2009年到他被任命为临时首席财务官期间（为公司在2013年7月的首次公开发行（ipo）的准备及其作为上市公司的财务报告提供援助）担任公司的顾问。从2004年到2014年他通过他的公司Timothy Daley CPA LLC（他是唯一负责人）为几个组织提供兼职和临时首席财务官/财务总监和证券交易委员会（SEC）报表服务。从1998年到2004年他担任各种财务职位，包括Sonic Foundry, Inc.的财务主管和财务总监。他在Coopers and Lybrand开始他的职业生涯，作为注册会计师见习。他持有圣母大学（the University of Notre Dame）的会计工商管理学士学位。
Timothy D. Daley served as a consultant to the Company from 2009 until he was appointed Interim Chief Financial Officer, providing assistance to the Company with its preparation for its initial public offering in July, 2013 and with its financial reporting as a public company. From 2004 to 2014 he provided part-time and interim CFO/Controller and SEC reporting services to several organizations through his firm Timothy Daley CPA LLC of which he was the sole principal. From 1998 to 2004 he held various finance positions, including Treasurer and Controller, at Sonic Foundry, Inc. Mr. Daley began his career at Coopers and Lybrand where he practiced as a certified public accountant. Mr. Daley holds a Bachelor of Business Administration, Accountancy from the University of Notre Dame.- Timothy D. Daley从2009年到他被任命为临时首席财务官期间（为公司在2013年7月的首次公开发行（ipo）的准备及其作为上市公司的财务报告提供援助）担任公司的顾问。从2004年到2014年他通过他的公司Timothy Daley CPA LLC（他是唯一负责人）为几个组织提供兼职和临时首席财务官/财务总监和证券交易委员会（SEC）报表服务。从1998年到2004年他担任各种财务职位，包括Sonic Foundry, Inc.的财务主管和财务总监。他在Coopers and Lybrand开始他的职业生涯，作为注册会计师见习。他持有圣母大学（the University of Notre Dame）的会计工商管理学士学位。
- Timothy D. Daley served as a consultant to the Company from 2009 until he was appointed Interim Chief Financial Officer, providing assistance to the Company with its preparation for its initial public offering in July, 2013 and with its financial reporting as a public company. From 2004 to 2014 he provided part-time and interim CFO/Controller and SEC reporting services to several organizations through his firm Timothy Daley CPA LLC of which he was the sole principal. From 1998 to 2004 he held various finance positions, including Treasurer and Controller, at Sonic Foundry, Inc. Mr. Daley began his career at Coopers and Lybrand where he practiced as a certified public accountant. Mr. Daley holds a Bachelor of Business Administration, Accountancy from the University of Notre Dame.
- Robert J. Palay
Robert J. Palay，是我们Cellular Dynamics International, Inc.公司的创立者并自2007年担任董事会主席和CEO。他之前在我们公司的前任公司成立时起直至2008年，担任董事会主席和CEO。他还联合创立了分子生物学工具公司NimbleGen Systems, Inc.，并于1999年至2007年担任董事会主席，于1999年至2000年担任该公司CEO。在这些公司成立时起，他担任一般合伙人的管理者或多个Tactics II机构的管理者，这些机构是私人投资工具，这些机构并在2014年1月之前是我们公司的部分主要股东。他在哈佛学院（Harvard College）以优异成绩获得学士学位，在凯洛格管理研究生院（the J.L. Kellogg Graduate School of Management）获得硕士学位，在西北大学法学院（Northwestern University School of Law）获得法学博士学位。
Robert J. Palay is one of our founders and has served as Chairman of the Board and as Chief Executive Officer since 2007. Mr. Palay previously served as chairman of the board and chief executive officer of each of our predecessors from their founding until 2008. He also co-founded NimbleGen Systems, Inc., a molecular biology tools company, and served as its chairman of the board from 1999 to 2007 and as its chief executive officer from 1999 to 2000. Since their inception, Mr. Palay has served as a manager of the general partner or manager of each of the various Tactics II entities, which are private investment vehicles and were among our principal shareholders prior to distributions made in 2014. He received a A.B., magna cum laude, from Harvard College, an M.M. from the J.L. Kellogg Graduate School of Management and a J.D. from the Northwestern University School of Law.- Robert J. Palay，是我们Cellular Dynamics International, Inc.公司的创立者并自2007年担任董事会主席和CEO。他之前在我们公司的前任公司成立时起直至2008年，担任董事会主席和CEO。他还联合创立了分子生物学工具公司NimbleGen Systems, Inc.，并于1999年至2007年担任董事会主席，于1999年至2000年担任该公司CEO。在这些公司成立时起，他担任一般合伙人的管理者或多个Tactics II机构的管理者，这些机构是私人投资工具，这些机构并在2014年1月之前是我们公司的部分主要股东。他在哈佛学院（Harvard College）以优异成绩获得学士学位，在凯洛格管理研究生院（the J.L. Kellogg Graduate School of Management）获得硕士学位，在西北大学法学院（Northwestern University School of Law）获得法学博士学位。
- Robert J. Palay is one of our founders and has served as Chairman of the Board and as Chief Executive Officer since 2007. Mr. Palay previously served as chairman of the board and chief executive officer of each of our predecessors from their founding until 2008. He also co-founded NimbleGen Systems, Inc., a molecular biology tools company, and served as its chairman of the board from 1999 to 2007 and as its chief executive officer from 1999 to 2000. Since their inception, Mr. Palay has served as a manager of the general partner or manager of each of the various Tactics II entities, which are private investment vehicles and were among our principal shareholders prior to distributions made in 2014. He received a A.B., magna cum laude, from Harvard College, an M.M. from the J.L. Kellogg Graduate School of Management and a J.D. from the Northwestern University School of Law.
- Thomas M. Palay
Thomas M. Palay，博士，是我们Cellular Dynamics International, Inc.公司的创建者之一，自2007年担任我们Cellular Dynamics International, Inc.公司的董事会副主席和总裁。他之前在我们Cellular Dynamics International, Inc.公司的各个前身公司成立时，担任其董事会副主席和总裁。他还联合创立了NimbleGen Systems, Inc.公司，于1999年至2007年担任该公司董事会副主席、副总裁和首席运营官。自公司的成立起，他担任一般合伙人经理或Tactics II实体的经理。他于1980年代成为威斯康星大学法学院（the University of Wisconsin Law School）教学人员。他于2010年在Foley & Lardner-Bascom法学教授职位上退休。他以优异成绩获得塔夫斯大学（Tufts University）学士学位，在宾夕法尼亚大学（the University of Pennsylvania）获得法学博士学位和博士学位。
Thomas M. Palay is one of our founders and has served as Vice Chairman of the Board and as President since 2007. Dr. Palay previously served as vice chairman of the board and president of each of our predecessors from their founding until 2008. He also co-founded NimbleGen Systems, Inc. and served as its vice chairman of the board, vice president and chief operating officer from 1999 to 2007. Since their inception, Dr. Palay has served as a manager of the general partner or manager of each of the Tactics II entities. Dr. Palay joined the faculty of the University of Wisconsin Law School in 1980. He retired as the Foley & Lardner-Bascom Professor of Law in 2010. Dr. Palay received a B.A., summa cum laude, from Tufts University, a J.D. from the University of Pennsylvania and a Ph.D. from the University of Pennsylvania.- Thomas M. Palay，博士，是我们Cellular Dynamics International, Inc.公司的创建者之一，自2007年担任我们Cellular Dynamics International, Inc.公司的董事会副主席和总裁。他之前在我们Cellular Dynamics International, Inc.公司的各个前身公司成立时，担任其董事会副主席和总裁。他还联合创立了NimbleGen Systems, Inc.公司，于1999年至2007年担任该公司董事会副主席、副总裁和首席运营官。自公司的成立起，他担任一般合伙人经理或Tactics II实体的经理。他于1980年代成为威斯康星大学法学院（the University of Wisconsin Law School）教学人员。他于2010年在Foley & Lardner-Bascom法学教授职位上退休。他以优异成绩获得塔夫斯大学（Tufts University）学士学位，在宾夕法尼亚大学（the University of Pennsylvania）获得法学博士学位和博士学位。
- Thomas M. Palay is one of our founders and has served as Vice Chairman of the Board and as President since 2007. Dr. Palay previously served as vice chairman of the board and president of each of our predecessors from their founding until 2008. He also co-founded NimbleGen Systems, Inc. and served as its vice chairman of the board, vice president and chief operating officer from 1999 to 2007. Since their inception, Dr. Palay has served as a manager of the general partner or manager of each of the Tactics II entities. Dr. Palay joined the faculty of the University of Wisconsin Law School in 1980. He retired as the Foley & Lardner-Bascom Professor of Law in 2010. Dr. Palay received a B.A., summa cum laude, from Tufts University, a J.D. from the University of Pennsylvania and a Ph.D. from the University of Pennsylvania.
- Emile F. Nuwaysir
Emile F. Nuwaysir，博士，于2008年担任Cellular Dynamics International, Inc.Cellular Dynamics International, Inc.公司的研究与开发、制造和质量体系副总裁、首席运营官。他是Invenra公司的创建者并担任董事，该公司是一家位于威斯康辛州的生物制药开发技术早期公司，于2011年设立。他之前于2007年至2008年担任Roche NimbleGen公司项目管理高级副总裁。在此之前，他于2003年至2007年担任NimbleGen Systems, Inc.公司商业开发副总裁，并于2000年至2003年担任NimbleGen Systems, Inc.公司多个科学的和管理职位，包括分子研究和开发部门负责人及技术和客户服务高级管理人。在进入NimbleGen Systems, Inc.公司之前，他在National Institutes of Health中的National Institute of Environmental Health Sciences进行博士后研究，在北卡罗来纳大学教堂山分校（the University of North Carolina-Chapel Hill）进行博士后研究，并在EI DuPont de Nemours Stine-Haskell Laboratory获得研究职位。他在特拉华大学（University of Delaware）获得学士学位，在威斯康星麦迪逊大学（the University of Wisconsin-Madison）获得肿瘤学方向的分子和环境毒理学博士学位， 并在McArdle 实验室进行癌症研究。
Emile F. Nuwaysir has served as Cellular Dynamics International, Inc. Vice President with responsibility for research and development, manufacturing and quality systems and as the Chief Operating Officer since 2008. He is a founder and has served as director of Invenra, a Wisconsin-based early stage company developing technology for biopharmaceutical discovery, since its inception in 2011. He previously served as senior vice president of program management at Roche NimbleGen from 2007 to 2008. Prior to this, he was vice president of business development at NimbleGen Systems, Inc. from 2003 to 2007 and held various scientific and managerial roles at NimbleGen Systems, Inc. from 2000 to 2003 including molecular research and development group leader and senior manager of technical and client services. Prior to NimbleGen Systems, Inc., he held a Postdoctoral Fellowship with the National Institute of Environmental Health Sciences within the National Institutes of Health, a postdoctoral fellowship at the University of North Carolina-Chapel Hill and a research position at EI DuPont de Nemours Stine-Haskell Laboratory. He earned his B.A. from the University of Delaware and his Ph.D. in Molecular and Environmental Toxicology with a focus in Oncology from the University of Wisconsin-Madison in the McArdle Laboratory for Cancer Research.- Emile F. Nuwaysir，博士，于2008年担任Cellular Dynamics International, Inc.Cellular Dynamics International, Inc.公司的研究与开发、制造和质量体系副总裁、首席运营官。他是Invenra公司的创建者并担任董事，该公司是一家位于威斯康辛州的生物制药开发技术早期公司，于2011年设立。他之前于2007年至2008年担任Roche NimbleGen公司项目管理高级副总裁。在此之前，他于2003年至2007年担任NimbleGen Systems, Inc.公司商业开发副总裁，并于2000年至2003年担任NimbleGen Systems, Inc.公司多个科学的和管理职位，包括分子研究和开发部门负责人及技术和客户服务高级管理人。在进入NimbleGen Systems, Inc.公司之前，他在National Institutes of Health中的National Institute of Environmental Health Sciences进行博士后研究，在北卡罗来纳大学教堂山分校（the University of North Carolina-Chapel Hill）进行博士后研究，并在EI DuPont de Nemours Stine-Haskell Laboratory获得研究职位。他在特拉华大学（University of Delaware）获得学士学位，在威斯康星麦迪逊大学（the University of Wisconsin-Madison）获得肿瘤学方向的分子和环境毒理学博士学位， 并在McArdle 实验室进行癌症研究。
- Emile F. Nuwaysir has served as Cellular Dynamics International, Inc. Vice President with responsibility for research and development, manufacturing and quality systems and as the Chief Operating Officer since 2008. He is a founder and has served as director of Invenra, a Wisconsin-based early stage company developing technology for biopharmaceutical discovery, since its inception in 2011. He previously served as senior vice president of program management at Roche NimbleGen from 2007 to 2008. Prior to this, he was vice president of business development at NimbleGen Systems, Inc. from 2003 to 2007 and held various scientific and managerial roles at NimbleGen Systems, Inc. from 2000 to 2003 including molecular research and development group leader and senior manager of technical and client services. Prior to NimbleGen Systems, Inc., he held a Postdoctoral Fellowship with the National Institute of Environmental Health Sciences within the National Institutes of Health, a postdoctoral fellowship at the University of North Carolina-Chapel Hill and a research position at EI DuPont de Nemours Stine-Haskell Laboratory. He earned his B.A. from the University of Delaware and his Ph.D. in Molecular and Environmental Toxicology with a focus in Oncology from the University of Wisconsin-Madison in the McArdle Laboratory for Cancer Research.
- Christopher Parker
Christopher Parker，他自2008年担任我们Cellular Dynamics International, Inc.公司的销售、市场和商业开发副总裁、首席商业官。之前他于2007年至2009年担任Stem Cell Products, Inc.公司首席商务官，于1998年至2007年担任Affymetrix, Inc.公司副总裁，负责全球制药业务部门的销售和市场副总裁。他还在Amersham Pharmacia Biotech Inc.公司药物开发服务团队工作，在麦迪逊大学人类肿瘤学系（the Department of Human Oncology at the University of Wisconsin-Madison）指导和从事分子和细胞生物学方面研究有数十年时间。
Christopher Parker has served as our Vice President with responsibility for sales, marketing and business development and our Chief Commercial Officer since 2008. He previously served as chief commercial officer of Stem Cell Products, Inc. from 2007 to 2009 and as vice president of Affymetrix, Inc. from 1998 to 2007 where he managed sales and marketing for the global pharmaceutical business unit. He also served on the drug discovery services team at Amersham Pharmacia Biotech Inc. and conducted research in molecular and cellular biology in the Department of Human Oncology at the University of Wisconsin-Madison for over a decade. He received a B.A. from the University of Wisconsin-Madison.- Christopher Parker，他自2008年担任我们Cellular Dynamics International, Inc.公司的销售、市场和商业开发副总裁、首席商业官。之前他于2007年至2009年担任Stem Cell Products, Inc.公司首席商务官，于1998年至2007年担任Affymetrix, Inc.公司副总裁，负责全球制药业务部门的销售和市场副总裁。他还在Amersham Pharmacia Biotech Inc.公司药物开发服务团队工作，在麦迪逊大学人类肿瘤学系（the Department of Human Oncology at the University of Wisconsin-Madison）指导和从事分子和细胞生物学方面研究有数十年时间。
- Christopher Parker has served as our Vice President with responsibility for sales, marketing and business development and our Chief Commercial Officer since 2008. He previously served as chief commercial officer of Stem Cell Products, Inc. from 2007 to 2009 and as vice president of Affymetrix, Inc. from 1998 to 2007 where he managed sales and marketing for the global pharmaceutical business unit. He also served on the drug discovery services team at Amersham Pharmacia Biotech Inc. and conducted research in molecular and cellular biology in the Department of Human Oncology at the University of Wisconsin-Madison for over a decade. He received a B.A. from the University of Wisconsin-Madison.
- Nicholas J. Seay
Nicholas J. Seay，自2007年担任我们Cellular Dynamics International, Inc.公司的总裁和首席技术官。1985年至2005年，他代表威斯康星校友研究基金会（WARF）成功成立了人类胚胎干细胞知识产权投资组合公司。他自1983年担任Epic Systems Corporation董事会成员，自2001年担任BellBrook Laboratories LLC董事会成员。加入我们Cellular Dynamics International, Inc.公司之前，1989年至2005年，他为生物技术公司提供顾问，并在Quarles and Brady LLP公司担任重要的技术职位，专门从事知识产权法律事务工作。他在康奈尔大学（Cornell University）获得学士学位，并在乔治华盛顿大学法学院（George Washington University Law School）获得法学博士学位。
Nicholas J. Seay has served as our Vice President and Chief Technology Officer since 2007. Representing WARF from 1985 to 2005 Mr. Seay successfully established its human embryonic stem cell intellectual property portfolio. Mr. Seay has served on the board of directors of Epic Systems Corporation since 1983 and BellBrook Laboratories LLC since 2001. Prior to joining our company, from 1989 to 2005 he advised biotechnology companies and worked on significant technologies at Quarles and Brady LLP, specializing in intellectual property law. Mr. Seay earned a B.S. from Cornell University and a J.D. from George Washington University Law School.- Nicholas J. Seay，自2007年担任我们Cellular Dynamics International, Inc.公司的总裁和首席技术官。1985年至2005年，他代表威斯康星校友研究基金会（WARF）成功成立了人类胚胎干细胞知识产权投资组合公司。他自1983年担任Epic Systems Corporation董事会成员，自2001年担任BellBrook Laboratories LLC董事会成员。加入我们Cellular Dynamics International, Inc.公司之前，1989年至2005年，他为生物技术公司提供顾问，并在Quarles and Brady LLP公司担任重要的技术职位，专门从事知识产权法律事务工作。他在康奈尔大学（Cornell University）获得学士学位，并在乔治华盛顿大学法学院（George Washington University Law School）获得法学博士学位。
- Nicholas J. Seay has served as our Vice President and Chief Technology Officer since 2007. Representing WARF from 1985 to 2005 Mr. Seay successfully established its human embryonic stem cell intellectual property portfolio. Mr. Seay has served on the board of directors of Epic Systems Corporation since 1983 and BellBrook Laboratories LLC since 2001. Prior to joining our company, from 1989 to 2005 he advised biotechnology companies and worked on significant technologies at Quarles and Brady LLP, specializing in intellectual property law. Mr. Seay earned a B.S. from Cornell University and a J.D. from George Washington University Law School.
- Anna M. Geyso
Anna M. Geyso，高级副总裁、总法律顾问和秘书。她于2011年3月担任我们Cellular Dynamics International, Inc.公司的秘书，并于2013年11月担任我们的高级副总裁、总法律顾问。1999年直至加入我们Cellular Dynamics International, Inc.公司，期间她是Godfrey & Kahn, S.C。股东，负责企业和证券法律领域事务。她在麦迪逊大学（the University of Wisconsin-Madison）获得工商管理学士，在密歇根大学法学院（the University of Michigan Law School）获得法学博士学位。
Anna M. Geyso has served as our Secretary since March 2011 and as our Senior Vice President and General Counsel since November 2013. From 1999 until she joined our company, she was a shareholder of Godfrey & Kahn, S.C. where she practiced in the corporate and securities law areas. Ms. Geyso received a B.B.A. in accounting with honors from the University of Wisconsin-Madison and a J.D. from the University of Michigan Law School.- Anna M. Geyso，高级副总裁、总法律顾问和秘书。她于2011年3月担任我们Cellular Dynamics International, Inc.公司的秘书，并于2013年11月担任我们的高级副总裁、总法律顾问。1999年直至加入我们Cellular Dynamics International, Inc.公司，期间她是Godfrey & Kahn, S.C。股东，负责企业和证券法律领域事务。她在麦迪逊大学（the University of Wisconsin-Madison）获得工商管理学士，在密歇根大学法学院（the University of Michigan Law School）获得法学博士学位。
- Anna M. Geyso has served as our Secretary since March 2011 and as our Senior Vice President and General Counsel since November 2013. From 1999 until she joined our company, she was a shareholder of Godfrey & Kahn, S.C. where she practiced in the corporate and securities law areas. Ms. Geyso received a B.B.A. in accounting with honors from the University of Wisconsin-Madison and a J.D. from the University of Michigan Law School.